Jiangxi Institute of Biological Products Inc. (HKG:6915)
Hong Kong · Delayed Price · Currency is HKD 10.74
+0.45 (4.37%)
At close: Oct 7, 2026
HKG:6915 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 407.89 | 73.83 | 52.83 | 58.2 |
Short-Term Investments | 9.32 | 0.28 | 0.22 | 0.08 |
Trading Asset Securities | - | - | 4.11 | - |
Cash & Short-Term Investments | 417.21 | 74.11 | 57.15 | 58.28 |
Cash Growth | - | 29.67% | -1.94% | - |
Accounts Receivable | 95.34 | 103.33 | 68.21 | 73.95 |
Other Receivables | - | 3.36 | 1.03 | 1.01 |
Receivables | 95.34 | 106.69 | 69.24 | 74.97 |
Inventory | 77.07 | 65.03 | 56.44 | 57.54 |
Restricted Cash | - | 1.56 | - | - |
Other Current Assets | 0.81 | 9.9 | 9.26 | 3.39 |
Total Current Assets | 590.42 | 257.29 | 192.08 | 194.18 |
Property, Plant & Equipment | 242.18 | 247.45 | 236.8 | 240.08 |
Other Intangible Assets | 0.31 | 0.37 | 0.5 | 0.63 |
Long-Term Deferred Tax Assets | 0.87 | 1.36 | 2.22 | 2.68 |
Other Long-Term Assets | 65.03 | 53.8 | 55.92 | 64.7 |
Total Assets | 898.81 | 560.28 | 487.52 | 502.27 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 6.14 | 6.52 | 13.02 | 12.81 |
Accrued Expenses | 23.99 | 29.77 | 34.47 | 37.04 |
Short-Term Debt | - | - | - | 19.92 |
Current Portion of Leases | 1.01 | 0.82 | - | 0.34 |
Current Income Taxes Payable | 1.05 | 7.54 | 8.69 | 0.86 |
Current Unearned Revenue | 2.44 | 1.94 | 2.44 | 3.1 |
Other Current Liabilities | 20.64 | 14.65 | 24.74 | 65.2 |
Total Current Liabilities | 55.26 | 61.24 | 83.36 | 139.27 |
Long-Term Leases | - | 0.07 | 0.72 | 0.86 |
Long-Term Unearned Revenue | 0.22 | 0.22 | 0.22 | 0.22 |
Long-Term Deferred Tax Liabilities | 0.66 | 0.73 | - | - |
Total Liabilities | 56.14 | 62.26 | 84.3 | 140.35 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 308.38 | 272.14 | 272.14 | 272.14 |
Retained Earnings | - | 189.32 | 94.52 | 60.21 |
Comprehensive Income & Other | 534.3 | 36.56 | 36.56 | 29.58 |
Total Common Equity | 842.68 | 498.02 | 403.22 | 361.94 |
Minority Interest | - | - | - | -0.01 |
Shareholders' Equity | 842.68 | 498.02 | 403.22 | 361.92 |
Total Liabilities & Equity | 898.81 | 560.28 | 487.52 | 502.27 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 1.01 | 0.89 | 0.72 | 21.12 |
Net Cash (Debt) | 416.2 | 73.22 | 56.43 | 37.16 |
Net Cash Growth | - | 29.74% | 51.87% | - |
Net Cash Per Share | 1.53 | 0.27 | 0.21 | 0.14 |
Filing Date Shares Outstanding | 308.38 | 272.14 | 272.14 | 272.14 |
Total Common Shares Outstanding | 308.38 | 272.14 | 272.14 | 272.14 |
Working Capital | 535.17 | 196.05 | 108.72 | 54.91 |
Book Value Per Share | 2.73 | 1.83 | 1.48 | 1.33 |
Tangible Book Value | 842.37 | 497.65 | 402.72 | 361.31 |
Tangible Book Value Per Share | 2.73 | 1.83 | 1.48 | 1.33 |
Buildings | - | 181.69 | 94.39 | 90.73 |
Machinery | - | 115.14 | 102.03 | 100.97 |
Construction In Progress | - | 17.96 | 93.83 | 90.71 |
Leasehold Improvements | - | 0.34 | 0.34 | 0.34 |